HIV Treatment Options For Patients Improve In Japan
This article was originally published in PharmAsia News
Executive Summary
Japan Tobacco brings Stribild home after U.S./EU launches by Gilead. Johnson & Johnson reduces patient burden with higher dose Prezista.